@article{f770e868cbab4b7d834966b35065517b,
title = "Neoadjuvant cisplatin and fluorouracil versus epirubicin, cisplatin, and capecitabine followed by resection in patients with oesophageal adenocarcinoma (UK MRC OE05): an open-label, randomised phase 3 trial",
keywords = "SQUAMOUS-CELL CARCINOMA, QUALITY-OF-LIFE, RESECTABLE GASTROESOPHAGEAL ADENOCARCINOMA, III TRIAL, PERIOPERATIVE CHEMOTHERAPY, PREOPERATIVE CHEMORADIOTHERAPY, JUNCTIONAL CANCER, TUMOR-REGRESSION, CLINICAL-TRIAL, SURGERY",
author = "Derek Alderson and David Cunningham and Matthew Nankivell and Blazeby, {Jane M.} and Griffin, {S. Michael} and Adrian Crellin and Grabsch, {Heike I.} and Rupert Langer and Susan Pritchard and Alicia Okines and Richard Krysztopik and Fareeda Coxon and Joyce Thompson and Stephen Falk and Clare Robb and Sally Stenning and Langley, {Ruth E.}",
year = "2017",
month = sep,
doi = "10.1016/S1470-2045(17)30447-3",
language = "English",
volume = "18",
pages = "1249--1260",
journal = "Lancet oncology",
issn = "1470-2045",
publisher = "Elsevier Science",
number = "9",
}